MedPath

Dutasteride for biopsy-negative benign prostate hyperplasia - effects on cancer detection and aging male symptoms

Not Applicable
Conditions
biopsy-negative benign prostate hyperplasia
Registration Number
JPRN-UMIN000005288
Lead Sponsor
Department of Urology, University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients with prostate cancer 2) patients with previous operation on prostate 3) Subjects taking any anti-androgen drugs 4) patients with prostatitis 5) Subjects with active urinary infection 6) Subjects with urethral catheter 7) Subjects with irritation to Eviprostat 8) Severe renal dysfunction 9) Severe liver dysfunction 10) Other ineligible subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cancer detection by prostatic biopsy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath